degree of heterogeneity of the clones generated with C57BL/6 regressor spleen cells. However, further analysis of such clones was limited by the relatively small number of cells available at any one time.
In the studies reported here, advantage was taken of the high frequency of operational CTL-P generated after in vitro stimulation of regressor spleen cell populations with MoLV-infected spleen cells. Large numbers of homogeneous CTL were obtained from such populations by first selecting and subsequently expanding clones obtained under limiting-dilution conditions. These expanded clones were then analyzed in detail for specificity, phenotypic stability, and Lyt phenotype.
Materials and Methods
Mice. Adult C57BL/6 (H-2 b) mice used in these experiments were bred in the animal facilities at the Swiss Institute for Experimental Cancer Research, Epalinges, Switzerland. Original breeding pairs were obtained from The Jackson Laboratory, Bar Harbor, Maine.
Tumor Cell Lines. MBL-2 (H-2b), an MoLV-induced lymphoma, and RBL-5 (H-2b), a Rauscher leukemia virus-induced lym~,homa, were maintained by serial passage of the ascitic forms in C57BL/6 mice. LSTRA (H-2), an MoLV-indueed lymphoma, and P-815 (H-2 d) and EL-4 (H-2b), chemically induced tumors, were maintained in vitro in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (FBS) .
Generatwn of CTL in Mass Culture. Regressor spleen cells were obtained from 3-to 4-wk-old C57BL/6 mice 14 d after an intramuscular injection of 0.1 ml of MoSV-MoLV complex (5) . Mass cultures were prepared with 30 × 106 regressor (responder) spleen cells and 6 × 106 MoLV-infected syngeneic (stimulator) spleen cells (mice were injected with a MoLV preparation within 24 h of birth, and spleen cells from these mice were used at 4 wk of age) 2 in 20 ml of Dulbecco's modified Eagle's medium supplemented with additional amino acids (14) , 5 × 10 -5 M 2-mercaptoethanol, and 2% FBS (culture medium), in upright 50-ml tissue culture flasks (Nunc, Roskilde, Denmark). After 7 d of culture at 37°C in a humidified atmosphere of 5% CO2 in air, an aliquot of cells was tested for cytolytic activity; the remaining cells, from several flasks, were pooled and frozen at -80°C in culture medium that contained 10% dimethyl sulfoxide (DMSO) and 10% FBS.
Micro-MLTC. Micro-MLTC were prepared in culture medium supplemented with 10% FBS and 25% (vol:vol) secondary mixed leukocyte culture (MLC) supernate (SN) (2 ° MLC SN) as a source of T cell growth factor (15) . Each culture contained limiting numbers of responder cells, 1 × 106 irradiated (2,000 rad) syngeneic spleen cells, and 3 X 104 irradiated (5,000 rad) syngeneic (stimulators) MBL-2 tumor cells in a final vol of 0.2 ml in roundbottomed microwelis (Greiner, Nfirtingen, Federal Republic of Germany) (13) . After 7 d of culture, cell growth was assessed microscopically and aliquots were removed to measure cytolytic activity.
Maintenance of CTL Clones. CTL clones derived from microcultures were transferred to and maintained in 1-ml cultures that contained 5 X 10 e irradiated (2,000 rad) syngeneic spleen cells and 3 × l0 s irradiated (5,000 rad) MBL-2 tumor cells in culture medium supplemented with 10% FBS and 25% MLC SN in 16-mm muhiwell plates (Costar, Data Packaging, Cambridge, Mass.). After initial expansion, clones were passaged every 3-5 d by transferring 5 × 104 cells to fresh cultures. Aliquots of cells were periodically frozen at -80°C in culture medium that contained 10% DMSO and 10% FBS.
Assay for Cytolytic Activity. Cytolytie activity of effeetor cells was determined using a 51Cr-release assay (16) . Briefly, aliquots of effector cells were mixed with either 2,000 or 5,000 51Cr-labeled tumor cells (as indicated) in a final vol of 200/zl in round-bottomed mieroplates and incubated for 3.5 h at 37°C. The assay plates were then centrifuged, and 100/zl of the SN fluid was removed and the amount of released 5~Cr determined in a well-type gamma counter. Controls included maximal release of 5tCr as the result of freezing and thawing targets, and spontaneous release of SXCr from labeled targets in the absence of effector cells. Percent-specific release or lyric units (LU) were calculated as previously described (16); 1 LU was equivalent to the number of lymphocytes required to produce 50% specific 5~Cr release.
Frequency of CTL-P. The method used for the calculation of CTL-P is described in detail elsewhere, a Briefly, 24 replicate microcultures prepared with varying numbers of responding cells were assessed for cytolytic activity. Positive cultures were defined as those in which the S~Cr release values exceeded by 3SD the spontaneous release values. Minimal estimates of CTL-P frequencies were calculated by analysis of the Poisson distribution relationship between the number of responding cells/mieroculture and the percentage of nonresponding cultures. Experimental values were fit to the zero-order-term Poisson equation by the maximum log likelihood method, a Alloantisera and Monoclonal Antibodies. Hyperimmune C57BL/6 anti-DBA/2 (anti-H-2 d) and DBA/2 anti-C67BL/6 (anti-H-2 b) ailoantisera were produced by intraperitoneal injection of recipient mice with 5 × 107 allogeneic spleen cells three to six times at 3-wk intervals. 7 d after the last injection, mice were exsanguinated and serum collected, filtered, and heat-inactivated.
Ascitic fluids that contained monoclonal antibodies produced by hybridomas B22-249.R1 and H141-30, specific for H-2D b, were obtained from G. H~mmerling, Deutsches Krebsforschungszentrum, Heidelberg, Federal Republic of Germany. Their reactivity patterns are described in detail elsewhere (17) . Serum that contained monoclonal antibody produced by the hybridoma B8-24-1, specific for H-2K b, was obtained from G. K6hler, Basel Institute for Immunology, Basel, Switzerland.
Concentrated culture SN that contained rat monoclonal antibodies directed against nonpolymorphic determinants of either Lyt-1 (53-7.3) or Lyt-2 (53-6.7) molecules were used in the analysis of the Lyt phenotype of MoLV-specific CTL clones. The reactivity pattern of these antibodies has previously been described (18) .
Fluorescein-labeled rabbit anti-rat IgG was purchased from Nordic Immunological Laboratories (Tilburg, The Netherlands).
Fluorescent Staining and Flow Cytometric Analysis. Indirect immunofluorescence was performed
on Ficoll-Hypaque-purified lymphoid cell samples of 0.3-1 X l0 s cells. Cells in a 0.1-ml vol were incubated with appropriate concentrations of rat monoclonal antibody directed against Lyt-1 or Lyt-2 at 4°C for 30 rain. After washing, cell pellets were resuspended for 30 min at 4°C in 0.1 ml of medium that contained fluoresceinated rabbit anti-rat IgG. Control samples were incubated in the fluorescein conjugate only. Samples were then finally centrifuged over a layer of FBS and analyzed on a flow eytometer (FACS II; B. D. FACS Systems, Mountain View, Calif.).
Flow cytometric analysis was performed as described in detail elsewhere. 4 Briefly, the FACS II, modified to allow three parameter analysis, was routinely gated for viable cells by a combination of narrow-angle forward light scatter and perpendicular light scatter. Fluorescence was the third parameter measured. Approximately 30,000 gated events were accumulated for each determination.
Results
Production of MoLV-Specific CTL Clones. Preliminary studies had shown that the frequency of MoLV-specific CTL-P increased dramatically (from -1/60o up to 1/2) after in vitro stimulation of C57BL/6 regressor spleen cells with syngeneic irradiated MoLV-induced MBL-2 lymphoma cells (or with MoLV-infected spleen cells). This suggested the use of in vitro stimulated cells as the starting population in attempts to derive MoLV-specific CTL clones, rather than the regressor spleen cells used in the previous studies (13) . Limiting numbers of cells (three cells/well) obtained at the peak z Taswell, C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. Manuscript submitted for publication.
4 MacDonald, H. R., R. K. Lees, B. Sordat, P. Zaech, J. L. Maryanski, and C. Bron. Age-associated increase in expression of the T cell surface markers Thy-1, Lyt-1 and Lyt-2 in congenitally athymic (nu/ nu) mice: analysis by flow microfluorometry. Manuscript submitted for publication.
of the CTL response (day 7) of C57BL/6 regressor spleen cells stimulated with MoLVinfected C57BL/6 spleen cells were cultured in micro-MLTC with 1 × 106 syngeneic irradiated spleen (accessory) cells and 3 × 104 irradiated MBL-2 tumor (stimulator) cells, and 2 ° MLC SN as a source oft cell growth factor. After 7 d, each culture was assessed microscopically for growth and an aliquot was tested for cytolytic activity against 51Cr-labeled MBL-2 target ceils. In one such experiment, 55 out of 96 microcuhures were positive for growth and all 55 demonstrated cytolytic activity. Cells from six highly cytolytic microcuhures were selected for expansion and transferred to 1-ml cultures that contained 5 × 108 irradiated C57BL/6 spleen cells, 3 × 105 irradiated MBL-2 cells, and 25% 2 ° MLC SN. Under these conditions, all six of these putative clonal isolates grew and were subsequently recloned 1 wk later by limiting-dilution in micro-MLTC with 0.3 responding cells/well (other attempts at expansion and recloning of micro-MLTC populations were similarly successful). All clones derived by this procedure were cytolytic for MBL-2 targets. These clones and others have been maintained in culture for >4 mo by passage of 5 × 104 cells every 3-5 d in 1-ml cultures that contained irradiated C57BL/6 syngeneic spleen cells, irradiated MBL-2 tumor cells, and 2 ° MLC SN.
To date, no clone has lost its high level of cytolytic activity or its cytolytic specificity. Fig. 1 compares the cytolytic activity of four of the derived clones. Although some degree of heterogeneity was seen, the levels of activity (50% lysis at effector:target cell ratios of0.3:1 to 3:1) were similar to or higher than those observed with mass cultures like those used to establish the clones (data not shown).
Karyotypic analysis of four of the clones carried for 4 mo in culture revealed the normal complement of mouse chromosomes, and no aberrant chromosomes were observed (M. Cianfriglia. Unpublished data.). 
Kinetics and Requirements for Growth of MoL V-specific CTL Clones.
To examine the growth requirements of MoLV-specific CTL clones, cultures were prepared with 5 × 104 cells from each of three clones using various supplements added to standard culture medium. Cell recovery and cytolytic activity against MBL-2 target cells were assessed on days 2, 3, 4, and 6. Fig. 2 illustrates the pattern of growth of a clone (C5.2) in the presence of the indicated culture supplements, and Table I presents * Cultures were prepared with 5 × 104 cells from the indicated CTL clone in 1 ml of culture medium plus the indicated culture supplement, i.e., irradiated syngeneic MBL-2 lymphoma cells (MBL-2); irradiated syngeneic spleen cells (irr. spleen), and 2 ° MLC SN (SN). After the indicated period of culture, cytolytic activity against nlCr-labeled MBL-2 target cells was assessed. LU were calculated from dose-response curves, 1 LU equals the number of lymphocytes required to produce 50% specific ~lCr release. The number of LU/108 lymphocytes or LU/culture was determined as described previously (t6).
these data that there is an absolute requirement for 2 ° MLC SN, but optimal cell recovery and cytolytic activity were also dependent upon the presence of syngeneic irradiated spleen cells and stimulating antigen (MBL-2). In general, peak cell recovery (ranging from 5 × 10 a to 3 × 10n/culture) was observed by day 4 and appeared to depend to some extent on the length of a lag period that all clones underwent after transfer. After the 6th d in culture, cell recovery and lytic activity diminished rapidly (data not shown).
Frequency Analysis of CTL-P in MoL V-specific Clones. Limiting-dilution analysis was used to determine the frequency of CTL-P in three clones. The frequency varied from 33-100%, suggesting a homogeneous population of cells with a high plating efficiency (Fig. 3) .
Lyt Antigen Phenotype of MoLV-specific CTL Clones. Flow cytometric analysis that employed monoclonal rat anti-Lyt-1 and anti-Lyt-2 antibodies was used to assess the Lyt phenotype of several of the MoLV-specific CTL clones. Fig. 4 compares the fluorescence profiles of three clones with those obtained with normal C57BL/6 thymocytes. It can be seen that both Lyt-1 and Lyt-2 antigens were expressed on the surface of the cells of all three clones. It should be noted that the relative amplification used to detect fluorescence on thymocytes was twice that used for the CTL clones. Thus, the Lyt-1 density of the CTL clones is at least equivalent to that on thymocytes, and Lyt-2 appears even more abundant. There was, however, heterogeneity in the density of Lyt antigens among the various clones, the quantity of Lyt-1 on clone B 11.1 being twice that seen on A2.2 or C5.2. The stability of this difference in antigen density with time was confirmed in determinations 2 mo apart.
Specificity ofMoLV-specific CTL clones. Previous studies in the MoLV system had demonstrated that CTL contained in mass MLTC populations preferentially lysed syngeneic MoLV-derived targets. However, significant lysis of allogeneic MoLVderived tumor ceils could also be observed at relatively high lymphocyte:target cell ratios (6) . Studies in micro-MLTC under limiting-dilution conditions further showed 100
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32. , or an aUogeneic non-MoLV-derived tumor (P-815). Two microcuhures (circled) were selected for further specificity studies after subeloning (Fig. 6 ).
demonstrated a high degree of specificity, lysing only MBL-2 targets, a smaller number demonstrated varying degrees of cross-reactivity with the other target cells. The remaining cells in two of these cultures (circled), one specific (D11) and one cross-reactive against LSTRA and P-815 (F9), were subcloned in micro-MLTC, expanded, and maintained in 1-ml cultures as described earlier in this report. The specificity of these 2 expanded CTL clones (and 12 others selected in a similar manner) was assessed using the 4 tumor targets employed in the initial screening procedure. At least three patterns of reactivity were observed, as illustrated by the three representative clones shown in Fig. 6 . Two of these (D11.F1S and F9.F8D) are subclones from microcuhures described in Fig. 5 . All three clones demonstrated high levels of cytolytic activity toward the syngeneic MoLV-derived tumor, MBL-2. However, although D11.F1S had no significant cytolytic activity against the other three targets tested (Fig. 6a) , A2.2 lysed LSTRA, though to a lesser extent, but again had no significant activity against EL-4 or P-815 (Fig. 6 b) . In contrast, F9.F8D lysed both P-815 and LSTRA in addition to the syngeneic MoLV-derived lymphoma (Fig.  6c) . As shown in Table II , of 14 selected clones, 6, 2, and 4 clearly exhibited the patterns exemplified by clones D11.F1S, A2.2, and F9.F8D, respectively. The likelihood that the F9.F8D pattern corresponds to clones that cross-react with H-2 d alloantigens was supported by the ability of DBA/2 (H-2d), but not C57BL/6 spleen cells, to effectively function as cold target inhibitors when Fg.FSD was assayed against MBL-2 or P-815, and by the ability of F9.F8D to lyse DBA/2, but not C57BL/6 concanavalin A blast target cells (data not shown).
Stability of Cytolytic Activity of MoLV-specific CTL Subclones. Three clones (A5, E6,
and C3) selected for their representative specificity patterns were subcloned by stimulating limiting numbers of cells from each clone in a series of micro-MLTC. From each parental clone, three randomly selected subclones were expanded and tested at different lymphocyte:target cell ratios for cytotoxicity against the four target cell types used for the initial selection. As shown in Fig. 7 , all three subclones of each parental clone closely resembled each other in its specificity pattern. This demonstrates a high degree of stability of activity and specificity of the subclones. Occasional retesting of individual subclones up to 4 mo after initial isolation confirmed this stability (data not shown.).
H-2D b Restriction of MoLV-specific CTL Clones. Previous reports (7) suggested that CTL of the H-2 b haplotype demonstrate H-2Db-restricted recognition of MoLVantigens; however, this restriction has not been examined at the clonal level. Therefore, we investigated whether lysis of MBL-2 target cells by the CTL clones reported here could be inhibited by alloantisera or monoclonal antibodies directed against H-2 determinants. Using conventional alloantisera, it was found that anti-H-2 b serum was a potent inhibitor of CTL activity, whereas anti-H-2 d serum had no detectable inhibitory activity (data not shown).
To further characterize the H-2 restriction of these CTL clones, monoclonal antibodies reactive with determinants encoded by H-2D b or H-2K b were used as inhibitors in the CTL assay. All of the six MoLV-specific CTL clones tested were inhibited by both of the anti-H-2D b monoclonal antibodies (B22-249.R1 and H 141-30), whereas the anti-K b monoclonal antibody (B8-24-1) had no effect (Fig. 8) . Control experiments established that the anti-K b monoclonal antibodies effectively inhibited alloreactive B10A (4R) anti-C57BL/6 (i.e., anti-K~ CTL. 5 Thus, based on the limited number of MoLV-specific clones examined, these observations support previous mass culture results (7) of H-2Db-restricted lysis in the MoLV system. Discussion Previous studies had shown the feasibility to isolate CTL clones specific for MoLV- 
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under limiting-dilution conditions (13) . However, the study of the specificity of such clones had been hampered by the limited number of cells generated. Our study shows that CTL clones obtained under limiting-dilution conditions can be expanded readily and maintained in culture for extended periods of time under appropriate culture conditions, i.e., in the presence of antigen (stimulating tumor or infected spleen cells), accessory cells (irradiated syngeneic spleen cells), and a source of T cell growth factor (TCGF) (2 ° MLC SN). The application of this technique provided large numbers of homogeneous CTL for detailed analysis of Lyt phenotype, specificity, and phenotypic stability.
Regressor spleen cells stimulated in mass culture with MoLV-infeeted spleen cells were used as a starting population to generate CTL clones. Limiting-dilution analysis indicated that the frequency of CTL-P in such populations had increased dramatically after in vitro stimulation, i.e., was between 15 and 50% (K. T. Brunner. Unpublished observations.). This allowed the use of very low responder cell numbers (2-3/micro-culture), thus increasing the probability that CTL contained in individual microcultures were derived from single precursor cells (i.e., were monoclonal) even at a relatively high percentage of positive cultures. Such putative clones were then selected, expanded, and recloned by limiting-dilution. Results comparing the cytolytic patterns of original and recloned populations in most instances suggested clonality of the original isolates (Fig. 7) .
Our study as well as those of Glasebrook and Fitch (19, 20) suggest an important role of antigen in the maintenance of specificity and high cytolytic activity during expansion of CTL clones in TCGF-containing medium. As reported by Nabholz et al. (21) , maintenance of cloned CTL lines in TCGF without additional antigen often led to loss of cytolytic activity, loss of specificity, and appearance of chromosomal aberrations. In contrast, such changes have not been observed with the MoLV-specific CTL clones reported here, at least within the 4-mo period during which they have been maintained in culture. Furthermore, the culture conditions used in our study appear to allow the isolation of large numbers of expanded CTL clones, insofar as 16 of 20 attempts to expand selected clones have been successful.
As assessed by flow microfluorometry using monoclonal antibodies, the MoLVspecific CTL clones tested expressed both Lyt-1 and Lyt-2 antigens. These findings are in apparent disagreement with those of Leclerc and Cantor (8) , who reported that the cytolytic activity of MoLV-specific CTL populations was unaffected by treatment with anti-Lyt-1 alloantiserum and complement. However, it is likely that this discrepancy can be explained by a relative resistance of CTL to lysis by anti-Lyt-1 antibody plus complement. Indeed, although early studies suggested that alloreactive CTL did not express Lyt-1 antigens, recent data from Nakayama et al. (22) and from this laboratory 6 clearly indicate that such CTL are Lyt-l+2 +. Thus, it is evident that the MoLV-specific clones reported here have the same Lyt phenotype as alloreactive CTL.
In previous studies, the specificity analysis of CTL clones derived from regressor spleens had demonstrated cross-reactivity of a small percentage of the clones (7%) with allogeneic tumor target cells (13) . Our studies confirm and extend these findings. Using four (two additional) target cell types, clones with three patterns of specificity were observed. A large majority of the clones was restricted to the syngeneic tumor, and a small (undetermined) percentage either cross-reacted with a MoLV-derived tumor or (apparently) with H-2 d alloantigens. 14 clones (Table II) were selected and analyzed for clonality and phenotypic stability after expansion and recloning. As shown in a representative experiment (Fig. 7) , a high degree of phenotypic stability was observed, with only minor differences in activity and specificity patterns between three subclones derived from each of three different cloned parent populations. Several of these clones were retested over a period of 4 mo, and all were found to maintain their high cytolytic activity and their specificity (A. Weiss. Unpublished results.).
In the studies reported here, interesting clones were selected on the basis of their specificity pattern. Certainly, these clones are not likely to represent the whole repertoire of MoLV antigen-reactive CTL-P in the C57BL/6 mouse, nor has any attempt been made to determine the frequency of clones that express any given phenotype. Studies in which individual CTL clones are tested for cytolytic activity against syngeneic target cells infected with other viruses and against various allogeneic target cells are required to further analyze the specificity repertoire of CTL in this system.
The restriction of MoLV-specific CTL for target cells that bear syngeneic H-2 determinants has been well documented (6, 7, 23, 24) . In particular, Gomard et al. (7) reported that in the H-2 b and H-2 d haplotypes, CTL recognition was restricted to the H-2D b and H-2K d regions, respectively. The studies reported here (and other studies) n that employed monoclonal anti-H-2K b and anti-H-2D b antibodies support and extend to the clonal level the conclusions of Gomard et al. (7) concerning the restriction of MoLV-specific CTL in the C57BL/6 mouse. All of 6 clones tested (and in other experiments 44 of 51 additional ones) 5 were inhibited by anti-H-2D b monoclonal antibodies, whereas none were inhibited by anti-H-2K b monoclonal antibodies. It remains to be determined whether the basis for such a high degree of restriction to H-2D b is related to the selective incorporation of H-2D b molecules into the virion envelope (25) . In view of a recent report that suggested that intact virus could substitute for tumor cells in the generation of MoLV-specific CTL in mass culture (26) , experiments are in progress to examine if viral preparations can be used as a source of antigen for the isolation and maintenance of CTL clones. Summary Cytolytic T lymphocyte (CTL) clones specific for Moloney leukemia virus (MoLV)-derived tumor cells were generated by placing limiting numbers ofC57BL/6 responder cells into mixed leukocyte-tumor cell microcultures. Under appropriate conditions (presence of stimulating tumor cells, accessory cells, and T cell growth factor), such cloned CTL could readily be expanded to provide large numbers of homogeneous, highly cytolytic CTL populations for further characterization. Using four target-cell types, three specificity patterns were observed: one reactive with the syngeneic MoLVderived tumor only, one cross-reactive with an allogeneic MoLV-derived tumor, and one cross-reactive with normal allogeneic cells. Subclones derived from these three types of clones exhibited a high degree of stability in terms of lytic activity and specificity over a 4-mo period of observation. Three clones analyzed by flow cytofluorometry using monoclonal antibodies were all found to be of the Lyt-1 +2 + phenotype. Furthermore, lysis of target cells by all of six clones tested was inhibited by anti-H-2D b (but not by anti-H-2K b) monoclonal antibodies, demonstrating H-2Db-restriction at the clonal level.
